Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO)
PROGRAMMA
si ringrazia per il contributo incondizionato:
TAILORING TREATMENT FOR LUNG CANCER
PATIENTS
CINBO
La partecipazione è gratuita.
Per accedere al Webinar collegarsi a
www.strategieonweb.it/ecm/tailoring-treatment-for-lung-cancer-patients-fad/
December 2-3, 2020
PROVIDER ECM ID. 50 PROVIDER ECM ID. 50 ORGANIZING ORGANIZING SECRETARIAT SECRETARIAT
Via Piave 110/7 - Pescara Phone: +39 085 74143
Fax +39 085 378220 [email protected] www.strategieonweb.it
OFFICES OFFICES
Consorzio Interuniversitario Nazionaleper la Bio-Oncologia (CINBO) c/o Sezione di Oncologia Medica Università G. D’Annunzio
Via dei Vestini, 31 66100 Chieti - Italy Phone: +39 0871 3556732 Fax +39 0871 3556707 [email protected]
Directors Directors
Clara Natoli Corrado Ficorella
Con il patrocinio di:
Sezione Regionale Abruzzo
Evento n. ECM 50-286078 Per Medici Chirurghi specialisti in:
ALLERGOLOGIA ED IMMUNOLOGIA CLINICA; GENETICA MEDICA; GERIATRIA; MALATTIE DELL’APPARATO RESPIRATORIO; MEDICINA INTERNA; ONCOLOGIA; RADIOTERAPIA; CHIRURGIA GENERALE;
ANATOMIA PATOLOGICA; MEDICINA NUCLEARE; RADIODIAGNOSTICA; CHIRURGIA TORACICA;
RADIODIAGNOSTICA; Per Farmacisti (Farmacia ospedaliera). Per Biologi.
Crediti ECM: 7
Educational School of Oncology - CINBO
15:00 Open on website
www.strategieonweb.it/fad/
16:00 Objectives of the course Clara Natoli & Corrado Ficorella
SESSION I - DECEMBER 02 SESSION I - DECEMBER 02 INTRODUCTION
INTRODUCTION
Moderator: Corrado Ficorella
16:15 The key role of pathology in lung cancer management Fiamma Buttitta, Chieti
16:30 Genomic and immunological characterization of NSCLC
Antonio Marchetti, Chieti 16:45 Advances in lung cancer imaging
Rosa Lucia Patea, Chieti 17:00 Discussion
17:30 End of the first day
SESSION II - DECEMBER 03 SESSION II - DECEMBER 03
EARLY AND LOCALLY ADVANCED NSCL CANCER EARLY AND LOCALLY ADVANCED NSCL CANCER Moderator: Michele De Tursi
15:00 Open on website
www.strategieonweb.it/fad/
15:15 Optimal management of stage I and II NSCLC Roberto Crisci, L’Aquila-Teramo
15:30 The role of surgery in locally advanced NSCLC Felice Mucilli, Chieti
15:45 Innovative radiotherapy approaches for stage III NSCLC Maria Taraborrelli, Chieti
16:00 Stage III immunotherapy, the clinical and scientific scenario
Luciana Irtelli - Pietro Di Marino, Chieti 16:15 Discussion
SESSION III - METASTATIC NSCLC SESSION III - METASTATIC NSCLC Moderator: Clara Natoli
16:30 Extracellular vesicles: a novel biomarker of response to cancer immunotherapy Davide Brocco, Chieti
16:45 Cytotoxic therapy and concurrent or sequential immunotherapy?
Michele De Tursi, Chieti
17:00 Resistance to immune checkpoint inhibitors Elisabetta Gambale, Siena
17:15 Discussion
17:30 Therapeutic strategy in EGFR + (exons 19-21 & exon 20) NSCLC patients
Rita Chiari, Padova
17:45 Therapeutic strategy in ALK+ and ROS1+ NSCLC patients Alessio Cortellini, L’Aquila
18:00 Targeted therapies going beyond EGFR, ALK and ROS1 Franco Calista, Campobasso
18:15 Discussion
18:30 Take-home messages and conclusions
